Latest filing published 07 May 2008 for Medite Cancer Diagnostics, Inc., €34k.
Insider track record
No signal scores available.
Closed purchases
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -85.7%Entry US$265.00 · Close at T+365 US$38.00
- -82.6%Entry US$345.00 · Close at T+365 US$60.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Daniel Joseph Burns: trading record in brief
Daniel Joseph Burns is a declared insider of Medite Cancer Diagnostics, Inc., with filings sourced from SEC (Form 4). The record holds 5 filings, for trades running from 5 December 2007 to 5 May 2008.
Every open-market trade on record is a purchase: 4 purchases worth €507k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 1 share grant. In 2008 alone, the filings show 4 purchases and no sales.
A typical purchase (the median) is worth €36k. Looking at 4 purchases old enough to measure, the stock rose over the following 90 days in 0% of cases; the median change was -26.7%. Past outcomes like these are no guarantee of what comes next.
The latest filing, published on 7 May 2008, reports an open-market purchase of €34k in Medite Cancer Diagnostics, Inc. Filings reach the SEC (Form 4) feed a median of 10 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Daniel Joseph Burns
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 20,000 shares@ US$2.65Common stock, $.001 parSEC:0001209191-08-028366:0Canonical exit: 31 Jul 2008 (T+90)
- 20,000 shares@ US$2.95Common stock, $.001 parSEC:0001209191-08-028366:1Canonical exit: 3 Aug 2008 (T+90)
- 100,000 sharesCommon Stock, $.001 parSEC:0001209191-08-020136:0
- 20,000 shares@ US$1.85Common stock, $.001 parSEC:0001209191-08-007121:0Canonical exit: 4 Mar 2008 (T+90)
- 300,000 shares@ US$2.00Common stock, $.001 parSEC:0001209191-08-007121:1Canonical exit: 21 Apr 2008 (T+90)
5 of 5 declarations